Related by context. Frequent words. (Click for all words.) 64 Pirfenidone 62 cSSSI 62 Icatibant 61 pseudobulbar affect PBA 61 Pivotal Trial 61 Pivotal Phase III 59 orphan designation 59 Nexavar ® 59 Marketing Authorization Application MAA 59 tanespimycin 58 Marketing Authorization 58 Orphan Drug status 57 NOXAFIL 57 Orphan Drug designation 57 hepatitis C HCV 57 refractory Hodgkin lymphoma 56 relapsed refractory multiple myeloma 56 Pivotal Phase 56 IV melanoma 56 phase IIa 56 Phenoptin 56 Mutual Recognition Procedure 56 Fast Track Designation 56 methylnaltrexone 56 Azedra 56 cutaneous T cell 56 Completes Enrollment 56 LymphoStat B 55 Tygacil 55 registrational 55 Allovectin 7 R 55 Marketing Authorization Application 55 BLA submission 55 axitinib 55 Investigational Device Exemption 55 Zelrix 55 Pixantrone 55 lymphoma CTCL 55 Vasovist 55 TORISEL 55 Phase 1b clinical 55 Orphan Drug Designation 55 Fast Track designation 55 FavId 55 Elesclomol 54 Orphan Drug Status 54 Celsion Corporation 54 PREOS 54 Swissmedic 54 romidepsin 54 confirmatory Phase III 54 alvimopan 54 ThermoDox ® 54 Phase III Trial 54 ATryn R 54 Gabapentin GR 54 Genasense R oblimersen 54 orphan medicinal product 53 Act PDUFA date 53 thymalfasin 53 Perifosine 53 phase 2a 53 Avastin bevacizumab 53 Phase IIa clinical 53 HER2 positive metastatic breast 53 pralatrexate 53 Cinryze TM 53 Torisel 53 Vilazodone 53 Anturol 53 Microcyn Technology 53 Relistor 53 Phase III clinical 53 Bronchitol 53 intravenous formulation 53 Phase 2b clinical 53 Cladribine Tablets 52 regadenoson 52 CoFactor 52 Rhucin ® 52 pivotal Phase III 52 Phase IIa trial 52 ONCONASE 52 Biologics License Application BLA 52 Cimzia R 52 Horizant 52 European Medicines Evaluation 52 confirmatory Phase 3 52 Abstral 52 REVLIMID R 52 Restanza 52 CORTOSS 52 Onsolis 52 Phase III pivotal 52 FDA Clearance 52 OTCQX RHHBY 52 castration resistant prostate cancer 52 NUVIGIL 52 Orphan Drug 52 relapsed multiple myeloma 52 alogliptin